Effect of the iron chelator deferoxamine on trichomonas vaginalis in vitro
Journal of the Egyptian Society of Parasitology. 2002; 32 (3): 691-704
in English
| IMEMR
| ID: emr-59730
ABSTRACT
The effect of 10 muMol, 15 muMol, 30 muMol and 60 muMol concentrations of deferoxamine [DFO], a clinically approved iron chelator, was determined on viability and multiplication of Trichomonas vaginalis grown in TYM axenic culture medium at 24 hours interval. DFO killed all T. vaginalis isolates with a minimum lethal concentration of 30 muMol after 48 hours culture incubation with the drug. A potent and persistent inhibitory effect of DFO on the parasite viability and multiplication was recorded throughout the study in a drug concentration and time exposure-dependent manner. Furthermore, this work studied the proteinase activity of T. vaginalis grown for 48 hours in DFO inoculated TYM medium and recorded a significant decrease by all drug concentrations applied. Different possible mechanisms of action of DFO against vaginalis and its possible use for treatment of trichomoniasis are discussed in this study
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Iron Chelating Agents
/
Treatment Outcome
/
Deferoxamine
Limits:
Female
/
Humans
Language:
English
Journal:
J. Egypt. Soc. Parasitol.
Year:
2002
Similar
MEDLINE
...
LILACS
LIS